Clinical trials
Phase 2 COVID-19 trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2020 | 20 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Terminated | 7 |
| Unknown status | 4 |
| Recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Azienda Ospedaliero, Universitaria Pisana | 2 |
| Azienda Ospedaliero-Universitaria di Parma | 2 |
| A.O.U. Città della Salute e della Scienza | 1 |
| ANRS, Emerging Infectious Diseases | 1 |
| AstraZeneca | 1 |
| Azienda Socio Sanitaria Territoriale di Mantova | 1 |
| Campus Bio-Medico University | 1 |
| Chiesi Farmaceutici S.p.A. | 1 |
| Dr. Spadera Lucrezia | 1 |
| Emanuele Bosi | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 29 |
| Coronavirus Infections | 7 |
| Pneumonia | 5 |
| Pneumonia, Viral | 3 |
| Respiratory Distress Syndrome | 2 |
| Respiratory Insufficiency | 2 |
| Anemia, Sickle Cell | 1 |
| Embolism and Thrombosis | 1 |
| Immunologic Deficiency Syndromes | 1 |
| Severe Acute Respiratory Syndrome | 1 |
Trials
Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.